| Literature DB >> 31406817 |
Fangqin Wu1, Ying Wu1, Wenyan Tao1, Haibo Zhao2, Dongyan Shen3.
Abstract
OBJECTIVES: Reported prediction rules for postoperative atrial fibrillation (AF) have suffered from inconsistent results and controversy surrounding the predictive value of a preoperative P-wave duration (PreOPWD). This study examined PreOPWD as a predictor for AF after coronary artery bypass grafting (CABG).Entities:
Keywords: Atrial fibrillation; Cohort studies; Coronary artery bypass; Meta-analysis; Off-pump
Year: 2018 PMID: 31406817 PMCID: PMC6626247 DOI: 10.1016/j.ijnss.2018.04.003
Source DB: PubMed Journal: Int J Nurs Sci ISSN: 2352-0132
Fig. 1Distribution of atrial fibrillation onset.
Preoperative patient characteristics.
| Characteristics | AF ( | non-AF | ||
|---|---|---|---|---|
| Age (years) | 65.94 ± 8.04 | 60.64 ± 9.50 | −4.767 | <0. 001 |
| Age ≥60 years | 77(77.8) | 105(52.5) | 17.765 | <0.001 |
| Male | 69(69.7) | 157(78.5) | 2.781 | 0.095 |
| Mean body mass index (kg/m2) | 25.48 ± 3.29 | 25.56 ± 3.40 | 0.189 | 0.850 |
| NYHA Classification | 5.465 | 0.141 | ||
| I | 58 (58.6) | 144 (72.0) | ||
| II | 32 (32.3) | 42 (21.0) | ||
| III | 7 (7.1) | 11 (5.5) | ||
| IV | 2 (2.0) | 3 (1.5) | ||
| Major comorbidities | ||||
| Hypertension | 81 (81.8) | 138 (69.0) | 5.552 | 0.018 |
| Diabetes mellitus | 29 (29.3) | 79 (39.5) | 2.990 | 0.084 |
| COPD | 4 (4.0) | 7 (3.5) | 0.054 | 0.817 |
| Myocardial infarction | 57(57.6) | 96 (48.0) | 2.430 | 0.119 |
| Cerebrovascular disease | 21 (21.2) | 30 (15.0) | 1.806 | 0.179 |
| Echocardiographic and ECG results | ||||
| Left atrial diameter (mm) | 37.02 ± 6.70 | 36.51 ± 5.28 | −0.722 | 0.471 |
| LVEF (%) | 62 ± 13 | 63 ± 12 | 0.485 | 0.628 |
| Aortic regurgitation | 16 (16.2) | 12 (6.0) | 8.056 | 0.005 |
| Mitral regurgitation | 26 (26.3) | 31 (15.5) | 4.971 | 0.026 |
| P-wave duration (ms) | 110.32 ± 13.13 | 102.28 ± 11.30 | −5.483 | <0.001 |
| P-wave duration ≥105 ms | 73(73.7) | 71(35.5) | 38.781 | <0.001 |
| Angiography results | ||||
| Triple vessel disease | 93(93.9) | 188(94.0) | 0.001 | 0.983 |
| Left main disease | 38 (38.4) | 72 (36.0) | 0.162 | 0.687 |
| Right coronary artery disease | 95 (96.0) | 193 (96.5) | 0.054 | 0.817 |
| Medication | ||||
| ACEI or ARB | 63 (63.6) | 137 (68.5) | 0.707 | 0.400 |
| Calcium channel blocker | 38 (38.4) | 72 (36.0) | 0.162 | 0.687 |
| β-blocker | 88 (88.9) | 179 (89.5) | 0.026 | 0.872 |
| Digoxin | 3 (3.0) | 8 (4.0) | 0.009 | 0.926 |
| Statins | 86 (86.9) | 174 (87.0) | 0.001 | 0.975 |
Data are presented as n (%) or means ± SD.
NYHA, New York Heart Association; COPD, chronic obstructive pulmonary disease; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.
Multivariate analysis of predictors of atrial fibrillation.
| Variables | 95% | ||
|---|---|---|---|
| Age (≥60 years) | 2.72 | 1.51–4.90 | 0.001 |
| Hypertension | 2.10 | 1.08–4.07 | 0.028 |
| P-wave duration (≥105 ms) | 4.63 | 2.66–8.03 | <0.001 |
HR, Hazard ratio; CI, confidence interval.
Fig. 2Study selection process. POAF, Postoperative atrial fibrillation.
Characteristics of studies included in the meta-analysis.
| First author(Ref#) | Year | Sample size( | The incidence of POAF(%) | Measurement of P wave duration |
|---|---|---|---|---|
| Klein M [ | 1995 | 16/29 | 36 | Lead II P wave duration measurement was performed manually by three independent observers. |
| Stafford PJ [ | 1997 | 51/138 | 27 | Lead II P wave duration measurement was performed manually by two independent observers. |
| Dimmer C [ | 1998 | 16/75 | 17.5 | Lead I, II and III P wave duration was calculated by three independent blinded observers. |
| Aytemir K [ | 1999 | 19/34 | 35.8 | Lead II P wave duration measurement was performed manually by two independent observers. |
| Chang CM [ | 1999 | 37/83 | 31 | Lead II, III, aVF and V2 P wave duration in three consecutive beats was confirmed by an experienced cardiologist. |
| Caravelli P [ | 2002 | 56/73 | 43 | One lead of lead I, II and III P wave duration was performed manually by two independent observers. |
| Amar D [ | 2004 | 508/1045 | 33 | Lead II P wave duration was measured manually according to previously defined values for prolonged P wave duration (>110 ms) or PR interval (>180 ms) |
| Chandy J [ | 2004 | 81/219 | 27 | Lead II P wave duration was measured manually. |
| Tongtong S [ | 2007 | 103/209 | 30 | Lead II P wave duration was measured manually by two independent observers. |
| Sovilj S [ | 2010 | 14/36 | 28 | Lead II P wave duration mean value and the standard deviation were calculated over all subsequent episodes of 15 min of the recorded data. |
| The present study | 2017 | 99/200 | 33.1 | The mean P-wave durations for at least three complexes were calculated in each lead by a blinded nurse with commercial software |
POAF, postoperative atrial fibrillation.
Fig. 3Preoperative P-wave duration and the risk of atrial fibrillation after CABG with WMDs and 95%CIs.